EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C58H66N10O9 |
| Net Charge | 0 |
| Average Mass | 1047.227 |
| Monoisotopic Mass | 1046.50142 |
| SMILES | NCCCC[C@@H]1NC(=O)[C@@H](Cc2cnc3ccccc23)NC(=O)[C@H](c2ccccc2)NC(=O)[C@@H]2C[C@@H](OC(=O)NCCN)CN2C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(OCc3ccccc3)cc2)NC1=O |
| InChI | InChI=1S/C58H66N10O9/c59-27-13-12-22-46-52(69)64-47(30-38-23-25-42(26-24-38)76-36-39-16-6-2-7-17-39)53(70)66-49(31-37-14-4-1-5-15-37)57(74)68-35-43(77-58(75)61-29-28-60)33-50(68)55(72)67-51(40-18-8-3-9-19-40)56(73)65-48(54(71)63-46)32-41-34-62-45-21-11-10-20-44(41)45/h1-11,14-21,23-26,34,43,46-51,62H,12-13,22,27-33,35-36,59-60H2,(H,61,75)(H,63,71)(H,64,69)(H,65,73)(H,66,70)(H,67,72)/t43-,46+,47+,48-,49+,50+,51+/m1/s1 |
| InChIKey | VMZMNAABQBOLAK-DBILLSOUSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Chemical Roles: | Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Biological Role: | hormone Originally referring to an endogenous compound that is formed in specialized organ or group of cells and carried to another organ or group of cells, in the same organism, upon which it has a specific regulatory function, the term is now commonly used to include non-endogenous, semi-synthetic and fully synthetic analogues of such compounds. |
| Application: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| pasireotide (CHEBI:72312) has role antineoplastic agent (CHEBI:35610) |
| pasireotide (CHEBI:72312) is a homodetic cyclic peptide (CHEBI:24613) |
| pasireotide (CHEBI:72312) is a peptide hormone (CHEBI:25905) |
| pasireotide (CHEBI:72312) is conjugate base of pasireotide(2+) (CHEBI:72315) |
| Incoming Relation(s) |
| pasireotide(2+) (CHEBI:72315) is conjugate acid of pasireotide (CHEBI:72312) |
| IUPAC Name |
|---|
| cyclo[(2S)-2-phenylglycyl-D-tryptophyl-L-lysyl-O-benzyl-L-tyrosyl-L-phenylalanyl-(4R)-4-{[(2-aminoethyl)carbamoyl]oxy}-L-prolyl] |
| INNs | Source |
|---|---|
| pasireotida | WHO MedNet |
| pasireotide | WHO MedNet |
| pasiréotide | WHO MedNet |
| pasireotidum | WHO MedNet |
| Synonyms | Source |
|---|---|
| cyclo((4R)-4-(2-aminoethylcarbamoyloxy)-L-prolyl-L-phenylglycyl-D-tryptophyl-L-lysyl-4-O-benzyl-L-tyrosyl-L- phenylalanyl-) | ChemIDplus |
| SOM 230 | ChemIDplus |
| SOM-230 | ChemIDplus |
| SOM230 | ChemIDplus |
| Manual Xrefs | Databases |
|---|---|
| D10147 | KEGG DRUG |
| Pasireotide | Wikipedia |
| Registry Numbers | Sources |
|---|---|
| Reaxys:9469122 | Reaxys |
| CAS:396091-73-9 | ChemIDplus |
| CAS:396091-73-9 | KEGG DRUG |
| Citations |
|---|